FDA approves Teva's generic version of Aciphex

02/22/2007 | Globes (Israel)

The FDA approved Teva Pharmaceutical Industries Ltd.'s generic version of Aciphex, an acid pump inhibitor made by Japan's Eisai Co. Ltd., a product with annual sales of $1.3 billion. A suit by Eisai against Teva over the drug's patent is pending in federal court in New York.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC